Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2017-05-03 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
2016年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2016 annual equity distribution plan by 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It details the dividend payment per 10 shares, the capital reserve conversion to shares, the record date, ex-dividend date, and the shareholders entitled to the distribution. It also includes information on the shareholding changes and the consultation contact details. The document is not a full annual report or financial statement but an announcement of dividend distribution and related equity changes following the shareholders' meeting approval. The document length is 2772 characters, which is relatively short and focused on dividend distribution details. Therefore, it fits the category of Notice of Dividend Amount (DIV) rather than a full report or other filing types.
2017-05-03 Chinese
2017年第一季度报告全文
Interim / Quarterly Report Classification · 95% confidence The document is titled as the "2017 年第一季度报告全文" which translates to "2017 First Quarter Report Full Text." It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and asset/liability changes for the first quarter of 2017. It also includes management's discussion of business risks, shareholder information, and operational highlights for the quarter. The length is substantial (15,000 characters), and the content includes actual financial statements and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and it is not a full annual report or other filing type. Therefore, the correct classification is IR with high confidence. Q1 2017
2017-04-25 Chinese
2017年第一季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (368 characters) stating that the company's 2017 first quarter report will be published on a specific date and website. It does not contain the actual financial data or report itself, but only informs investors about the upcoming release. According to the MENU VS MEAL RULE, this is a Report Publication Announcement (RPA), not the actual Interim/Quarterly Report (IR).
2017-04-25 Chinese
2016年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2016 Annual General Meeting (AGM) of 福安药业 (Fuan Pharmaceutical Group Co., Ltd.). It details the meeting date, voting procedures, attendance, and the results of various proposals including approval of the 2016 annual reports, financial statements, audit reports, profit distribution, capital changes, and amendments to the company charter. It also includes legal opinions on the meeting's legality. The document does not contain the full annual report or financial statements themselves but references that these reports were published separately on the regulatory website. The document is essentially an official announcement of the voting results and resolutions passed at the AGM, not the report or financial statements themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5024 characters, which is consistent with a detailed voting results announcement rather than a full report.
2017-04-21 Chinese
2016年度股东大会之法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2016 Annual General Meeting (AGM) of Fu'an Pharmaceutical (Group) Co., Ltd. It details the procedures for convening and holding the AGM, the qualifications of attendees, the voting procedures, and the results of various resolutions passed at the AGM. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and resolutions. This type of document is typically associated with materials shared during the AGM or related to the AGM process. Therefore, the document fits best under the category of AGM Information (AGM-R).
2017-04-21 Chinese
关于公司股东、董事、监事及高级管理人员不减持公司股份的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from the company 福安药业 (Fuan Pharmaceutical) regarding a commitment by the company's controlling shareholders, directors, supervisors, and senior management not to reduce their shareholdings within a specified six-month period. It includes details about the commitment, references to regulatory compliance, and mentions recent financial performance figures as context. The document does not contain detailed financial statements or comprehensive report data but is focused on shareholding and management commitments. This fits the category of Major Shareholding Notification (MRQ), as it relates to significant share ownership and related commitments by key insiders.
2017-04-16 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.